Loading stock data...

Blue Jet Healthcare Limited

NSE: BLUEJET BSE: BLUEJET

NSE
656.40 9.05 (1.40%)

Prev Close

647.35

Open Price

647.35

Volume

212,670

Today Low / High

640.1 / 661.5

52 WK Low / High

468.5 / 1027.8

Range

624 - 689

BSE
656.30 8.65 (1.34%)

Prev Close

647.65

Open Price

656

Volume

31,290

Today Low / High

640.1 / 661.8

52 WK Low / High

467.8 / 1028.2

Range

623 - 689

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 656.4 (target range: 624 - 689), reflecting a change of 9.05 (1.39801%). On the BSE, it is listed at 656.3 (target range: 623 - 689), showing a change of 8.65 (1.3356%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

31 Oct 647.35 1.80%
30 Oct 654.00 -1.02%
29 Oct 638.80 2.01%
28 Oct 641.90 -0.48%
27 Oct 650.00 -2.26%
24 Oct 658.65 -2.12%
23 Oct 671.00 -2.98%
21 Oct 665.00 -0.33%
20 Oct 665.00 -0.58%
17 Oct 670.00 -2.49%
16 Oct 665.00 0.98%
15 Oct 657.05 0.73%
14 Oct 664.40 -1.10%
13 Oct 671.00 -1.07%
10 Oct 656.90 3.18%
09 Oct 670.00 -2.46%
08 Oct 673.95 -1.54%
07 Oct 683.00 -1.33%
06 Oct 668.85 2.02%
03 Oct 684.00 -3.02%

Blue Jet Healthcare Limited Graph

Blue Jet Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Blue Jet Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 656.40, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 656.30 662.86 596.58 - 729.15
669.43 535.54 - 803.31
675.99 473.19 - 878.79
Bearish Scenario 656.30 649.74 584.76 - 714.71
643.17 514.54 - 771.81
636.61 445.63 - 827.59

Overview of Blue Jet Healthcare Limited

ISIN

INE0KBH01020

Industry

Biotechnology

Vol.Avg

556,909

Market Cap

114,296,368,533

Last Dividend

1.2

Official Website

Visit Website

IPO Date

2023-11-01

DCF Diff

365.45

DCF

276

Financial Ratios Every Investor Needs

Stock Dividend of BLUEJET

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-19 September 19, 25 1.2 1.2 2025-09-19 2025-10-25
2024-09-17 September 17, 24 1 1 2024-09-18 2024-10-24

Stock Rating Details for BLUEJET

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 3 Neutral
ROE Score 5 Strong Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 1,029.99 Cr 461.22 Cr 568.76 Cr 0.5522 0.00 Cr 10.85 Cr 359.94 Cr 305.20 Cr 17.59 423.99 Cr 0.2963
2024-03-31 710.32 Cr 321.19 Cr 389.13 Cr 0.5478 0.00 Cr 7.62 Cr 337.22 Cr 163.75 Cr 9.44 248.35 Cr 0.2305
2023-03-31 718.48 Cr 448.16 Cr 270.32 Cr 0.3762 0.00 Cr 5.44 Cr 196.36 Cr 160.03 Cr 9.23 243.04 Cr 0.2227
2022-03-31 676.78 Cr 380.20 Cr 296.58 Cr 0.4382 0.00 Cr 4.15 Cr 222.43 Cr 181.59 Cr 10.47 268.68 Cr 0.2683
2021-03-31 494.21 Cr 246.73 Cr 247.48 Cr 0.5008 0.00 Cr 6.39 Cr 185.12 Cr 138.42 Cr 7.98 215.46 Cr 0.2801

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 119.79 Cr 1,417.53 Cr 284.42 Cr 1,133.1110 Cr 19.99 Cr -99.80 Cr 263.92 Cr 388.94 Cr 0.45 Cr 0.00 Cr 0.00 Cr 255.9070 Cr
2024-03-31 40.95 Cr 1,058.85 Cr 213.62 Cr 845.2230 Cr 1.61 Cr -39.34 Cr 129.84 Cr 318.80 Cr 0.00 Cr 0.00 Cr 15.00 Cr 205.9640 Cr
2023-03-31 65.44 Cr 862.07 Cr 180.58 Cr 681.4860 Cr 3.44 Cr -62.00 Cr 129.14 Cr 193.41 Cr 0.02 Cr 0.00 Cr 0.00 Cr 173.8790 Cr
2022-03-31 75.37 Cr 713.38 Cr 191.83 Cr 521.5420 Cr 17.32 Cr -58.06 Cr 105.70 Cr 161.92 Cr 0.04 Cr 0.00 Cr 0.00 Cr 174.5040 Cr
2021-03-31 61.13 Cr 536.28 Cr 196.46 Cr 339.8180 Cr 51.62 Cr -8.01 Cr 118.62 Cr 144.91 Cr 7.41 Cr 0.01 Cr 0.00 Cr 163.1050 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 45.7650 Cr -35.1830 Cr -18.5570 Cr -34.1150 Cr -7.9750 Cr 32.9790 Cr -79.8800 Cr 305.2030 Cr -1.1120 Cr -17.3490 Cr -134.0880 Cr
2024-03-31 241.2570 Cr -263.7550 Cr -1.9860 Cr 66.9590 Cr -24.4840 Cr 40.9540 Cr -174.2980 Cr 163.7510 Cr -1.8250 Cr -0.0020 Cr -4.1770 Cr
2023-03-31 141.5500 Cr -147.2520 Cr -4.2330 Cr 82.2790 Cr -9.9350 Cr 65.4380 Cr -59.2710 Cr 160.0270 Cr -2.8800 Cr -0.0020 Cr -20.6270 Cr
2022-03-31 146.4170 Cr -76.0260 Cr -56.1450 Cr 120.7510 Cr 14.2460 Cr 75.3730 Cr -22.9220 Cr 181.5910 Cr -52.5580 Cr -0.0020 Cr 12.6850 Cr
2021-03-31 129.9170 Cr -56.6480 Cr -22.1900 Cr 80.7670 Cr 51.0550 Cr 61.1270 Cr -49.1500 Cr 141.6160 Cr -22.2430 Cr -0.0020 Cr -48.6990 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 354.76 Cr 182.90 Cr 171.86 Cr 0.4844 115.30 Cr 91.17 Cr 5.26 129.25 Cr 0.2570
2025-03-31 340.45 Cr 153.47 Cr 186.97 Cr 0.5492 135.02 Cr 110.10 Cr 6.35 139.47 Cr 0.3234
2024-12-31 318.38 Cr 144.42 Cr 173.96 Cr 0.5464 119.27 Cr 98.98 Cr 5.71 137.26 Cr 0.3109
2024-09-30 208.26 Cr 109.53 Cr 98.73 Cr 0.4741 64.87 Cr 58.35 Cr 3.36 81.56 Cr 0.2802
2024-06-30 162.90 Cr 92.08 Cr 70.82 Cr 0.4348 40.78 Cr 37.78 Cr 2.18 52.98 Cr 0.2319

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 306.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,133.11 Cr
2025-03-31 119.79 Cr 186.69 Cr 306.48 Cr 349.53 Cr 263.92 Cr 1,005.95 Cr 388.94 Cr 1,417.53 Cr 284.42 Cr
2024-12-31 0.00 Cr 0.00 Cr 364.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -924.00 Cr
2024-09-30 29.83 Cr 334.58 Cr 374.31 Cr 211.56 Cr 178.03 Cr 795.66 Cr 352.69 Cr 1,181.03 Cr 257.03 Cr
2024-06-30 -320.19 Cr 640.39 Cr 320.19 Cr 0.00 Cr 0.00 Cr 320.19 Cr 0.00 Cr 0.00 Cr -845.22 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 91.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 110.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 98.98 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 58.35 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 37.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹372.10 ₹496,781,777,367.00 ₹2,111,938.00
Anthem Biosciences Ltd. ANTHEM ₹710.10 ₹398,799,297,215.00 ₹343,569.00
Piramal Pharma Limited PPLPHARMA ₹199.63 ₹264,339,882,238.00 ₹1,739,695.00
Syngene International Limited SYNGENE ₹650.10 ₹260,939,987,388.00 ₹435,567.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,854.10 ₹212,341,202,986.00 ₹120,757.00
Concord Biotech Limited CONCORDBIO ₹1,443.80 ₹151,044,875,335.00 ₹41,125.00
Blue Jet Healthcare Limited BLUEJET ₹656.40 ₹113,862,704,970.00 ₹212,670.00
Jubilant Ingrevia Limited JUBLINGREA ₹689.95 ₹108,993,347,159.00 ₹251,771.00
Supriya Lifescience Limited SUPRIYA ₹776.90 ₹62,527,087,320.00 ₹1,252,724.00
Zota Health Care Limited ZOTA ₹1,511.00 ₹45,832,641,705.00 ₹42,257.00
Dishman Carbogen Amcis Limited DCAL ₹291.80 ₹45,749,307,121.00 ₹350,194.00

Key Executives

Company Secretary & Compliance Officer
Ms. Sweta Poddar

Gender: female

Year Born:

Chief Operating Officer
Mr. Vimalendu Kumar Singh

Gender: male

Year Born:

Executive Director
Mr. Popat B. Kedar

Gender: male

Year Born:

President of Research & Development
Mr. Chandrashekar Parenky

Gender: male

Year Born:

Executive Director
Mr. Naresh Suryakant Shah

Gender: male

Year Born: 1965

MD & Director
Mr. Shiven Akshay Arora

Gender: male

Year Born: 1993

Executive Chairman
Mr. Akshay Bansarilal Arora

Gender: male

Year Born: 1963

Head of Business Development
Ms. Archana Akshay Arora

Gender: female

Year Born: 1969

Chief Financial Officer
Mr. Ganesh Karuppannan

Gender: male

Year Born:

FAQs about Blue Jet Healthcare Limited

Who is the CEO of the company?

The CEO is Akshay Bansarilal Arora.

What is the current market price of the stock?

The current price is ₹658.90.

What is the 52-week price range?

The range is ₹468.5-1027.8.

What is the market capitalization of the company?

The market capitalization is ₹11,429.64 crores.

What is the dividend yield?

The dividend yield is 0.18%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 31.85.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Blue Jet Healthcare Limited (ISIN: INE0KBH01020) is a leading Biotechnology in India. With a market capitalization of ₹11,429.64 crores and an average daily volume of 556,909 shares, it operates in the Biotechnology. The company last declared a dividend of ₹1.2.